ArticleOncology reports2022

Icariin inhibits the malignant progression of lung cancer by affecting the PI3K/Akt pathway through the miR‑205‑5p/PTEN axis.

Fengjie Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.